Origin and Function of Monocytes in Inflammatory Bowel Disease
DOI: https://doi.org/10.2147/jir.s450801
IF: 4.5
2024-05-14
Journal of Inflammation Research
Abstract:Xiping Liao, 1, 2, &ast Ji Liu, 3, &ast Xiaolong Guo, 1 Ruiping Meng, 1 Wei Zhang, 1 Jianyun Zhou, 1 Xia Xie, 1, 2 Hongli Zhou 1 1 Clinical Medical Research Center, the Second Affiliated Hospital, Army Medical University, Chongqing, People's Republic of China; 2 Department of Gastroenterology, the Second Affiliated Hospital, Army Medical University, Chongqing, People's Republic of China; 3 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xia Xie, Department of Gastroenterology, the Second Affiliated Hospital, Army Medical University, No. 83 Xinqiao Main Street, Shapingba District, Chongqing, 400037, People's Republic of China, Email Hongli Zhou, Clinical Medical Research Center, the Second Affiliated Hospital, Army Medical University, No. 83 Xinqiao Main Street, Shapingba District, Chongqing, 400037, People's Republic of China, Email Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic disease resulting from the interaction of various factors such as social elements, autoimmunity, genetics, and gut microbiota. Alarmingly, recent epidemiological data points to a surging incidence of IBD, underscoring an urgent imperative: to delineate the intricate mechanisms driving its onset. Such insights are paramount, not only for enhancing our comprehension of IBD pathogenesis but also for refining diagnostic and therapeutic paradigms. Monocytes, significant immune cells derived from the bone marrow, serve as precursors to macrophages (M&phiss) and dendritic cells (DCs) in the inflammatory response of IBD. Within the IBD milieu, their role is twofold. On the one hand, monocytes are instrumental in precipitating the disease's progression. On the other hand, their differentiated offsprings, namely moM&phiss and moDCs, are conspicuously mobilized at inflammatory foci, manifesting either pro-inflammatory or anti-inflammatory actions. The phenotypic spectrum of these effector cells, intriguingly, is modulated by variables such as host genetics and the subtleties of the prevailing inflammatory microenvironment. Notwithstanding their significance, a palpable dearth exists in the literature concerning the roles and mechanisms of monocytes in IBD pathogenesis. This review endeavors to bridge this knowledge gap. It offers an exhaustive exploration of monocytes' origin, their developmental trajectory, and their differentiation dynamics during IBD. Furthermore, it delves into the functional ramifications of monocytes and their differentiated progenies throughout IBD's course. Through this lens, we aspire to furnish novel perspectives into IBD's etiology and potential therapeutic strategies. Keywords: IBD, monocytes, inflammatory response Inflammatory Bowel Disease (IBD) is a chronic and complex intestinal inflammatory disorder. Recent clinical data have shown promising results in IBD treatment through the combination of Granulocyte-Monocytes Apheresis with certain pharmacological agents. 1–4 This emerging evidence highlights the potential efficacy of monocytes-based interventions in IBD, despite the absence of well-established therapeutic guidelines. Moreover, extensive basic research has elucidated the pivotal role of monocytes in the pathogenesis and progression of IBD. Monocytes, integral components of the immune system, are produced in the bone marrow and play a vital role in maintaining intestinal homeostasis through processes such as recruitment, activation and differentiation. 5–8 In patients with IBD, there is typically an overabundance of highly active monocytes in the intestinal milieu. These monocytes contribute significantly to the inflammatory cascade by releasing pro-inflammatory cytokines and chemokines, thereby recruiting additional immune cells to the site of inflammation. 9–14 For example, monocytes-derived cytokines, including IL-1β, IL-6, and IL-23, have the capacity to activate T cells within the innate layer of the intestinal mucosa. This, in turn, results in the production of additional inflammatory cytokines, thereby amplifying the inflammatory response within the intestinal tract. 14–16 Furthermore, chemokines released by monocytes, such as CCL11, can attract other immune cells, including neutrophils and eosinophils, to sites of inflammation, exacerbating tissue damage within the intestine (Figure 1). 17,18 Figure 1 Recruitment of Immune Cells by Monocytes in IBD. Through the secretion of cytokines, including chemokines and other inflammatory mediators, monocyte -Abstract Truncated-
immunology